Følg
Kathryn M. Ferguson
Titel
Citeret af
Citeret af
År
Structural basis for inhibition of the epidermal growth factor receptor by cetuximab
S Li, KR Schmitz, PD Jeffrey, JJW Wiltzius, P Kussie, KM Ferguson
Cancer cell 7 (4), 301-311, 2005
13372005
An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors
AW Burgess, HS Cho, C Eigenbrot, KM Ferguson, TPJ Garrett, DJ Leahy, ...
Molecular cell 12 (3), 541-552, 2003
13132003
EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization
KM Ferguson, MB Berger, JM Mendrola, HS Cho, DJ Leahy, MA Lemmon
Molecular cell 11 (2), 507-517, 2003
10222003
Signal-dependent membrane targeting by pleckstrin homology (PH) domains
MA LEMMON, KM FERGUSON
Biochemical Journal 350 (1), 1-18, 2000
9992000
Structure of the high affinity complex of inositol trisphosphate with a phospholipase C pleckstrin homology domain
KM Ferguson, MA Lemmon, J Schlessinger, PB Sigler
Cell 83 (6), 1037-1046, 1995
7731995
Specific and high-affinity binding of inositol phosphates to an isolated pleckstrin homology domain.
MA Lemmon, KM Ferguson, R O'Brien, PB Sigler, J Schlessinger
Proceedings of the National Academy of Sciences 92 (23), 10472-10476, 1995
7321995
PH domains: diverse sequences with a common fold recruit signaling molecules to the cell surface
MA Lemmon, KM Ferguson, J Schlessinger
Cell 85 (5), 621-624, 1996
6061996
The EGFR family: not so prototypical receptor tyrosine kinases
MA Lemmon, J Schlessinger, KM Ferguson
Cold Spring Harbor perspectives in biology 6 (4), a020768, 2014
4862014
Structure-based view of epidermal growth factor receptor regulation
KM Ferguson
Annu. Rev. Biophys. 37, 353-373, 2008
4702008
Identification and analysis of PH domain‐containing targets of phosphatidylinositol 3‐kinase using a novel in vivo assay in yeast
SJ Isakoff, T Cardozo, J Andreev, Z Li, KM Ferguson, R Abagyan, ...
The EMBO journal, 1998
4351998
Structural basis for discrimination of 3-phosphoinositides by pleckstrin homology domains
KM Ferguson, JM Kavran, VG Sankaran, E Fournier, SJ Isakoff, ...
Molecular cell 6 (2), 373-384, 2000
4142000
Epidermal growth factor receptor dimerization and activation require ligand-induced conformational changes in the dimer interface
JP Dawson, MB Berger, CC Lin, J Schlessinger, MA Lemmon, ...
Molecular and cellular biology 25 (17), 7734-7742, 2005
4062005
Crystal structure at 2.2 Å resolution of the pleckstrin homology domain from human dynamin
KM Ferguson, MA Lemmon, J Schlessinger, PB Sigler
Cell 79 (2), 199-209, 1994
3491994
Pleckstrin homology domains and the cytoskeleton
MA Lemmon, KM Ferguson, CS Abrams
FEBS letters 513 (1), 71-76, 2002
3442002
EGFR ligands differentially stabilize receptor dimers to specify signaling kinetics
DM Freed, NJ Bessman, A Kiyatkin, E Salazar-Cavazos, PO Byrne, ...
Cell 171 (3), 683-695. e18, 2017
3172017
A biparatopic anti‐EGFR nanobody efficiently inhibits solid tumour growth
RC Roovers, MJWD Vosjan, T Laeremans, R el Khoulati, RCG de Bruin, ...
International journal of cancer 129 (8), 2013-2024, 2011
2872011
The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand
S Bouyain, PA Longo, S Li, KM Ferguson, DJ Leahy
Proceedings of the National Academy of Sciences 102 (42), 15024-15029, 2005
2632005
Structural evaluation of EGFR inhibition mechanisms for nanobodies/VHH domains
KR Schmitz, A Bagchi, RC Roovers, PMPB en Henegouwen, ...
Structure 21 (7), 1214-1224, 2013
2212013
Matuzumab binding to EGFR prevents the conformational rearrangement required for dimerization
J Schmiedel, A Blaukat, S Li, T Knöchel, KM Ferguson
Cancer cell 13 (4), 365-373, 2008
2042008
Extracellular domains drive homo‐but not hetero‐dimerization of erbB receptors
KM Ferguson, PJ Darling, MJ Mohan, TL Macatee, MA Lemmon
The EMBO journal, 2000
1942000
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20